|
|
|
Insider
Information: |
Albers Jeffrey W. |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
180,202 |
|
Indirect Shares
|
34,360 |
|
|
Direct
Value |
$18,586,743 |
|
|
Indirect Value
|
$20,640 |
|
|
Total
Shares |
214,562 |
|
|
Total
Value |
$18,607,383 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
0.0%
|
151.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Blueprint Medicines Corp |
BPMC |
|
2024-03-20 |
176,050 |
|
0 |
Premium* |
|
Dianthus Therapeutics Ord Shs |
DNTH |
Director |
2018-06-25 |
4,152 |
2018-06-25 |
0 |
Premium* |
|
Aeglea Biotherapeutics, Inc. |
AGLE |
|
2023-11-24 |
0 |
2023-11-24 |
34,360 |
Premium* |
|
Kymera Therapeutics, Inc. |
KYMR |
|
2024-02-21 |
0 |
2024-01-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-06-12 |
4 |
OE |
$1.87 |
$37,400 |
D/D |
20,000 |
48,961 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-06-17 |
4 |
AS |
$99.06 |
$495,300 |
D/D |
(5,000) |
28,961 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-06-17 |
4 |
OE |
$1.87 |
$9,350 |
D/D |
5,000 |
33,961 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-08-19 |
4 |
AS |
$81.33 |
$1,634,661 |
D/D |
(20,000) |
28,961 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-08-19 |
4 |
OE |
$1.87 |
$37,400 |
D/D |
20,000 |
48,961 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-10-30 |
4 |
OE |
$1.87 |
$37,400 |
D/D |
20,000 |
48,961 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-11-08 |
4 |
AS |
$74.56 |
$875,633 |
D/D |
(11,744) |
48,961 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-11-18 |
4 |
AS |
$75.36 |
$622,652 |
D/D |
(8,256) |
60,705 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2019-11-18 |
4 |
OE |
$1.87 |
$51,260 |
D/D |
20,000 |
68,961 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
123,711 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-03-09 |
4 |
S |
$51.97 |
$118,336 |
D/D |
(2,277) |
121,434 |
0 |
% |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-03-23 |
4 |
AS |
$50.40 |
$1,041,922 |
D/D |
(20,000) |
141,434 |
0 |
% |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-03-23 |
4 |
OE |
$1.87 |
$212,846 |
D/D |
40,000 |
161,434 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-05-12 |
4 |
AS |
$63.93 |
$1,293,427 |
D/D |
(20,000) |
141,434 |
0 |
% |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-05-12 |
4 |
OE |
$8.80 |
$176,000 |
D/D |
20,000 |
161,434 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-08-19 |
4 |
AS |
$74.60 |
$1,500,438 |
D/D |
(20,000) |
141,434 |
0 |
% |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-08-19 |
4 |
OE |
$8.80 |
$176,000 |
D/D |
20,000 |
161,434 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-10-07 |
4 |
AS |
$99.17 |
$495,850 |
D/D |
(5,000) |
141,434 |
0 |
% |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-10-07 |
4 |
OE |
$8.80 |
$44,000 |
D/D |
5,000 |
146,434 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-11-16 |
4 |
AS |
$97.61 |
$1,974,295 |
D/D |
(20,000) |
141,434 |
0 |
% |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-11-16 |
4 |
OE |
$8.80 |
$176,000 |
D/D |
20,000 |
161,434 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-12-14 |
4 |
AS |
$119.18 |
$595,900 |
D/D |
(5,000) |
141,434 |
0 |
% |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2020-12-14 |
4 |
OE |
$8.80 |
$44,000 |
D/D |
5,000 |
146,434 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
181,434 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
CEO and President |
|
2021-03-04 |
4 |
AS |
$86.61 |
$1,695,006 |
D/D |
(18,986) |
172,448 |
0 |
% |
|
107 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|